AI assistant
Sending…
Xylem Inc. — Director's Dealing 2012
Dec 4, 2012
30109_dirs_2012-12-04_78572605-e14e-4615-b427-c63b9fbdbcf9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Xylem Inc. (XYL)
CIK: 0001524472
Period of Report: 2012-11-30
Reporting Person: Kuchenbrod Michael (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-30 | Common Stock | M | 16031 | $17.353 | Acquired | 35384 | Direct |
| 2012-11-30 | Common Stock | S | 16031 | $25.9922 | Disposed | 19353 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-11-30 | Employee Stock Option (Right to Buy) | $17.353 | M | 16031 | Disposed | 2013-01-04 | Common Stock (16031) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6063.5266 | Indirect |
Footnotes
F1: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $25.98 to $26.02 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
F2: As of November 30, 2012.
F3: These options are fully vested and exercisable.
More from Xylem Inc.
Prospectus
2026
May 21
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 19
Prospectus
2026
May 19
Regulatory Filings
2026
May 18
Registration Form
2026
May 18
Interim / Quarterly Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Mar 30
Director's Dealing
2026
Mar 3